Effect of basal insulin supplement therapy on diabetic retinopathy in short-duration type 2 diabetes: A one-year randomized parallel-group trial.
Pan-Wei MuXi-Xiang TangYing TanYi-Na WangShuo LinMan-Man WangJiong ShuJing WangYong-Jun ZhangHua LiangBai-Run LinMeng-Yin CaiYan-Ming ChenPublished in: Journal of diabetes (2019)
Twelve months of BOT decreased the incidence of DR in short-duration type 2 diabetes by reducing glycemia more effectively, stably, and completely than OADs alone.
Keyphrases
- type diabetes
- diabetic retinopathy
- glycemic control
- phase iii
- phase ii
- optical coherence tomography
- open label
- double blind
- clinical trial
- cardiovascular disease
- study protocol
- insulin resistance
- risk factors
- placebo controlled
- randomized controlled trial
- adipose tissue
- stem cells
- metabolic syndrome
- editorial comment
- weight loss
- cell therapy